FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

900000000000526001: REPLACED BY association reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)


16226 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
REPLACED BY association reference set (foundation metadata concept) Is a Historical association reference set (foundation metadata concept) true Inferred relationship Some

Members targetComponentId
Peripheral neuropathy due to chemotherapy Peripheral neuropathy due to and following antineoplastic therapy (disorder)
Peritoneal packing procedures Insertion of pack into peritoneal cavity (procedure)
Peritoneal venous shunt patency test for Leveen shunt Peritoneovenous shunt patency test
Peritoneovenous shunt for ascites (& [LeVeen] or [Denver]) Creation of peritoneal-venous shunt
Permethrin stain Permethrin (substance)
Pernasal swab Swab of internal nose (specimen)
Persistent femoral anteversion Persistent congenital anteversion of femur (disorder)
Persistent flow of blood into graft of aorta Persistent flow of blood into aneurysm sac following endovascular insertion of stent graft into aorta
Persistent flow of blood into stent graft region Persistent flow of blood into aneurysm sac following endovascular insertion of stent graft (disorder)
Person in family of subject Person in the family (person)
Personal history of primary malignant neoplasm of skin History of primary malignant neoplasm of skin (situation)
Personal mobility assistive device Mobility aid (physical object)
Personality finding Character trait finding
Pesticide product overdose Pesticide poisoning
Petechiae in fetus OR newborn Perinatal cutaneous petechiae (disorder)
Petit mal Absence seizure
Petroleum poisoning Toxic effect of petroleum product
Phalanx of second finger Structure of phalanx of index finger
Pharmaceutical lubricant agent Medicinal product acting as lubricant (product)
Pharyngorrhaphy for cleft palate Repair of cleft palate
Pharyngoscopy: [diagnostic NOS] or [NEC] Endoscopy of pharynx (procedure)
Pharynx excision Pharyngectomy
Pheasant adenovirus 1 Turkey adenovirus 3 (organism)
Phendimetrazine tartrate 105mg capsule Phendimetrazine only product in oral dose form
Phendimetrazine tartrate 105mg m/r capsule Phendimetrazine only product in oral dose form
Phendimetrazine tartrate 105mg prolonged-release oral capsule Phendimetrazine only product in oral dose form
Pheniramine 0.0315%/naphazoline 0.02675% ophthalmic solution Naphazoline hydrochloride 270 microgram/mL and pheniramine maleate 3.15 mg/mL eye solution
Phenobarbital 20mg/5mL elixir Product containing precisely phenobarbital 4 milligram/1 milliliter conventional release oral solution (clinical drug)
Phenothiazine overdose Phenothiazine and/or phenothiazine derivative overdose
Phenoxybenzamine hydrochloride 50mg/mL infusion concentrate 2mL ampule Product containing precisely phenoxybenzamine hydrochloride 50 milligram/1 milliliter conventional release solution for injection (clinical drug)
Phenoxymethylpenicillin 0.3% eye drops Phenoxymethylpenicillin potassium 3 mg/mL eye solution
Phenylacetate--CoA ligase Phenylacetate--CoA ligase
Phenylbutylpiperadine derivative antipsychotic agent Phenylbutylpiperadine derivative
Phenylephrine 0.125% solution nasal drops Product containing precisely phenylephrine hydrochloride 1.25 milligram/1 milliliter conventional release nasal solution (clinical drug)
Phenylephrine 0.25% solution nasal Product containing precisely phenylephrine hydrochloride 2.5 milligram/1 milliliter conventional release nasal solution (clinical drug)
Phenylephrine 0.25% solution oral drop Phenylephrine 2.5 mg/mL oral solution
Phenylephrine 0.5% solution nasal Product containing precisely phenylephrine hydrochloride 5 milligram/1 milliliter conventional release nasal solution (clinical drug)
Phenylephrine 1% solution nasal Phenylephrine hydrochloride 10 mg/mL nasal solution
Phenylephrine 5mg/promethazine 6.25mg/codeine 10mg in 5mL oral syrup Codeine phosphate 2 mg/mL and phenylephrine hydrochloride 1 mg/mL and promethazine hydrochloride 1.25 mg/mL oral solution
Phenylephrine hydrochloride 10% conventional release eye drops Phenylephrine hydrochloride 100 mg/mL eye solution
Phenylephrine hydrochloride 10% single-use eye drops Phenylephrine hydrochloride 100 mg/mL eye solution
Phenylephrine hydrochloride 2.5% conventional release eye drops Phenylephrine hydrochloride 25 mg/mL eye solution
Phenylephrine hydrochloride 2.5% single-use eye drops Phenylephrine hydrochloride 25 mg/mL eye solution
Phenylephrine hydrochloride 2.5% solution Product containing only phenylephrine (medicinal product)
Phenylpiperazine antidepressant Phenylpiperazine derivative (substance)
Phenylpropanolamine hydrochloride adverse reaction Adverse reaction to phenylpropanolamine
Phenylpropanolamine hydrochloride allergy Allergy to phenylpropanolamine (finding)
Phenytoin sodium 30mg m/r capsule Phenytoin only product in oral dose form
Phenytoin sodium 30mg prolonged-release oral capsule Phenytoin only product in oral dose form
Phialophora richardsiae Pleurostomophora richardsiae (organism)
Philadelphia chromosome positive chronic myelogenous leukemia Chronic myeloid leukemia
Phocanema decipiens Pseudoterranova decipiens
Pholcoline Pholcodine (substance)
Phosphocol, p-32 15mCi injection suspension 10mL vial Chromic phosphate (32-P) only product in parenteral dose form
Phospholipase specific extract Product containing phospholipase (medicinal product)
Phospholipid + protein 35mg/0.65mg suspension Product containing only calfactant (medicinal product)
Phosphoric diester hydrolase Phosphoric diester hydrolase
Phosphoric monoester hydrolase Substance with phosphoric monoester hydrolase mechanism of action (substance)
Phosphorus-32(diagnostic) Product containing phosphorus-32 (medicinal product)
Phosphorus-oxygen lyase Phosphorus-oxygen lyase
Phosphotransferase Kinase
Photoptarmosis Photoptarmosis
Photorhabdus luminescens subspecies thracensis Photorhabdus temperata subspecies thracensis (organism)
Photosensitising drugs Drug or medicament (substance)
Phototherapy &/or radiation therapy Radiotherapy
Phthalic anhydride specific extract Phthalic anhydride
Phylum Thermomicrobia Class Thermomicrobia (organism)
Phylum acanthocephala Phylum Acanthocephala (organism)
Phylum microspora Phylum Microsporidia (organism)
Physical examination - action Examination - action
Physical medicine iontophoresis Iontophoresis procedure
Physical medicine service Physical medicine service (qualifier value)
Physical science technician Physics technician
Physiological jaundice (& [NOS]) Newborn physiological jaundice
Physostigmine 0.25% eye drops Product containing precisely physostigmine salicylate 2.5 milligram/1 milliliter conventional release eye solution (clinical drug)
Physostigmine 0.5% eye drops Product containing precisely physostigmine salicylate 5 milligram/1 milliliter conventional release eye solution (clinical drug)
Physostigmine+pilocarpine 0.25%+2% eye drops Physostigmine salicylate 2.5 mg/mL and pilocarpine hydrochloride 20 mg/mL eye solution
Physostigmine+pilocarpine 0.25%+4% eye drops Product containing precisely physostigmine salicylate 2.5 milligram/1 milliliter and pilocarpine hydrochloride 40 milligram/1 milliliter conventional release eye solution (clinical drug)
Physostigmine+pilocarpine 0.5%+4% eye drops Product containing precisely physostigmine salicylate 5 milligram/1 milliliter and pilocarpine hydrochloride 40 milligram/1 milliliter conventional release eye solution (clinical drug)
Pichia ohmeri Kodamaea ohmeri (organism)
Pick's cell Niemann-Pick cell
Picornavirus Family Picornaviridae (organism)
Pigeon droppings protein Pigeon droppings
Pigmented nevus, no International Classification of Diseases for Oncology subtype Pigmented nevus
Pigmented skin lesion of suspected malignant nature Suspected malignant pigmented skin lesion (situation)
Pigmented villonodular synovitis Diffuse tenosynovial giant cell tumor
Pigmented villonodular synovitis Diffuse tenosynovial giant cell tumor
Pilocarpine hydrochloride 10% eye drops Product containing precisely pilocarpine hydrochloride 100 milligram/1 milliliter conventional release eye solution (clinical drug)
Pilocarpine hydrochloride 5.0mg tablet Product containing precisely pilocarpine hydrochloride 5 milligram/1 each conventional release oral tablet (clinical drug)
Pilocarpine nitrate 1% conventional release eye drops Product containing only pilocarpine in ocular dose form (medicinal product form)
Pilocarpine nitrate 1% single-use eye drops Product containing only pilocarpine in ocular dose form (medicinal product form)
Pilocarpine nitrate 2% conventional release eye drops Product containing only pilocarpine in ocular dose form (medicinal product form)
Pilocarpine nitrate 2% single-use eye drops Product containing only pilocarpine in ocular dose form (medicinal product form)
Pilocarpine nitrate 4% conventional release eye drops Product containing only pilocarpine in ocular dose form (medicinal product form)
Pilocarpine nitrate 4% single-use eye drops Product containing only pilocarpine in ocular dose form (medicinal product form)
Pilocarpine nitrate 4% single-use eye drops Product containing only pilocarpine in ocular dose form (medicinal product form)
Pilocytic astrocytoma Pilocytic astrocytoma
Pilonidal cyst with no abscess Pilonidal cyst
Pink color Pink color (qualifier value)
Pioglitazone 15mg + metformin 1g m/r tablet Metformin and pioglitazone only product in oral dose form
Pioglitazone 15mg + metformin 1g prolonged-release oral tablet Metformin and pioglitazone only product in oral dose form

Start Previous Page 98 of 163 Next End


Reference Sets

Reference set descriptor

Back to Start